Pantel, Klaus
Hayes, Daniel F.
Article History
First Online: 21 November 2017
Competing interests
: K.P. has received research funding from Janssen Diagnostics. D.F.H. receives research funding from Astra Zeneca, Eli Lilly, Merrimack, Pfizer, and Puma; honoraria from Janssen Diagnostics; is the named inventor on a patent held by the University of Michigan on the CTC-Endocrine Therapy Index; receives annual royalties from the commercial manufacturer of CellSearch<sup>®</sup> (previously Janssen, now Menarini Silicon Biosystems); is an adviser and board member of Pfizer; and has stock options in InBiomotion and OncImmune.